If approved, it will be the first GLP-1 to treat MASH, and an FDA decision is anticipated by the third quarter of 2025
Injection Site Reactions As with any peptide injection, minor redness, swelling, or irritation at the injection site can occur
However, if these medications are needed for a man to avoid long-term narcotic use, these non-opioid alternatives appear to be a much better choice in terms of maintaining good sperm quality
Raise awareness and help others who want to hear success stories as well as challenges
In anesthesia, one of the first risks to manage in patients is that of aspiration
Key insights on endometriosis R&D Watch our short video for an overview of our findings Infographic: PCOS R&D This infographic highlights key messages from Flying Blind, focusing on research and development in PCOS